X
20
Fresenius Kabi Oncology Limited Kalyani In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Oxaliplatin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-193 - Rev 05
This Chemical Type CEP, issued on September 24, 2021, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2017 associated with this CEP further emphasizes